NEW · Pharmaceuticals
JNJ
Johnson & Johnson · $617.01B
256.03
-1.02%
Price
251 sessions shownTechnicals
from daily closesRSI · 14 day
28.3
Avg true range · 14d
1.90%
Volatility · 20d annualised
14.4%
Trend · 20d vs 50d
Up
vs 20-day average
-4.34%
vs 50-day average
-3.75%
vs 200-day average
5.93%
200-day average
241.71
Internals
where it sits, and how hard it is being traded52-week low
182.94
52-week high
281.07
Volume vs its 20-day avg
1.73×
Beta vs the market
0.20
Sitting 74% of the way up its 52-week range (182.94 → 281.07)
Swings
prices it actually turned at — highest or lowest of the surrounding 11 sessionsTurned down · Aug 19
276.47
Turned down · Sep 2
281.07
Turned down · Sep 24
275.23
Turned up · Aug 4
250.44
Turned up · Aug 27
263.83
Turned up · Sep 15
260.68
Fundamentals
P/E
29.33
Fwd P/E
—
P/S
6.30
P/B
6.13
EV/EBITDA
19.97
ROE
25.7%
ROA
10.6%
Gross margin
68.1%
Net margin
—
Debt / equity
0.59
Rev growth
8.1%
EPS growth
17.9%
Every figure here is measured from live market data as of Oct 4, 05:03 PM. Nothing is estimated or filled in — where a figure shows — the source had no value for it, and a section you don’t see had no data at all. This describes what the market has already done. It is not a forecast, and not financial advice.